Chronic Pain Programs
Customize your policy alerts
Sign up for Aetna Policy 0237 alerts
Get alerted when Policy 0237 changes without checking for updates manually.
Monitor payer policy activity
Defines medical necessity, limitations, and exclusions for outpatient and inpatient multidisciplinary chronic pain management programs for Aetna members, including screening, admission criteria, and interventions considered experimental.
No material clinical or coverage changes in this revision.
Coverage Criteria for Multidisciplinary Chronic Pain Programs
inv-01: Outpatient multidisciplinary pain management — Initial admission — Covered when ALL of the following are met
Covered when ALL of the following are met
inv-02: Inpatient multidisciplinary pain management — Initial admission (up to 21 days) — Covered when ALL of the outpatient criteria are met AND all of the following are met
Covered when ALL of the outpatient criteria are met AND all of the following are met
Maximum recommended medically necessary stay is up to 21 days; stays beyond require medical necessity review.
inv-03: Contraindications / Not medically necessary for program entry — Entry is not medically necessary if ANY of the following are present
Entry is not medically necessary if ANY of the following are present
inv-04: Inpatient program limitations — 1 top-level node
inv-05: Modality-oriented and single-disciplinary clinics — 1 top-level node
Modality-oriented pain clinics and single‑disciplinary pain clinics are considered not medically necessary and inappropriate for comprehensive treatment of chronic pain.
This Clinical Policy Bulletin provides a partial, general description of plan or program benefits and is intended to assist in administering benefits; it is not an offer of coverage, a contract, or medical advice. Coverage for a specific member is determined by the member’s plan provisions, program disclosures, and prior authorization processes — confirm plan‑specific benefits and authorization requirements before providing services.
Neuropsychological evaluation and testing is considered not medically necessary when it is performed solely for consideration of treatment with narcotic (opioid) pharmacotherapy without broader multidisciplinary assessment or treatment planning.
Coding and Diagnosis
| 0117U | Pain management, analysis of 11 endogenous analytes, LC-MS/MS, urine, algorithm reported as a pain-index score |
| 96132 | Neuropsychological testing evaluation services |
| 96133 | Neuropsychological testing evaluation services (component) |
| 96146 | Psychological or neuropsychological test administration, automated instrument, automated result only |
| 99453 | Remote monitoring of physiologic parameter(s), initial; set-up and patient education |
| 99454 | Remote monitoring device supply with daily recordings or programmed alerts, each 30 days |
| 99457 | Remote physiologic monitoring treatment management services, first 20 minutes |
| 99458 | Remote physiologic monitoring treatment management services, each additional 20 minutes |
| 64553-64595 | Neurostimulators |
| 90785 | Interactive complexity (add-on) |
| G89.21-G89.3 | Chronic pain, not elsewhere classified |
| G89.4 | Chronic pain syndrome |
Provider Actions, Authorization, and Documentation
Prior authorization required for inpatient stays >21 days
Participation in inpatient multidisciplinary pain management programs beyond the routinely allowed duration requires prior medical necessity review and authorization; the policy states participation for more than 21 days is subject to medical necessity review.
Confirm plan-specific prior authorization and program provisions
Verify plan-specific program provisions and any prior authorization processes before arranging admission; the Clinical Policy Bulletin is a general guide and plan provisions determine coverage and authorization requirements.
Require failure of conventional treatments prior to outpatient program entry
Members must have failed conventional methods of treatment before entry into an outpatient multidisciplinary chronic pain management program; this failure is a required admission criterion.
No explicit step therapy specified
No explicit step therapy protocol is specified in this policy; the document states no additional step therapy requirements are detailed in these sections.
Required documentation to support program admission
Documentation must show prior treatment attempts, chronic pain duration of 6 months or more, mental health evaluation and treatment of primary psychiatric conditions where indicated, functional impairment, and referral by the primary/attending physician.
- Evidence of failed conventional treatments and prior interventions
- Duration of pain ≥ 6 months
- Mental health evaluation and treatment where indicated
- Functional impairment and referral from primary/attending physician
Provider responsibility — clinical care vs. benefit guidance
Treating providers are solely responsible for medical advice and treatment of members; the Clinical Policy Bulletin is for benefit administration and is not a contract or a substitute for clinical judgment.
Inpatient length limits and pre-admission evaluation rules
Inpatient participation beyond 21 days is subject to medical necessity review and inpatient admission solely for pre-admission medical or psychological evaluations is considered not medically necessary.
- Pre-admission medical and psychological evaluations should be performed outpatient; inpatient admission for these evaluations is not medically necessary
- Participation >21 days requires review
Contraindications that may result in denial of program entry
Entry into outpatient or inpatient programs may be denied if contraindications exist, including aggressive or violent behavior, imminently suicidal tendencies, prior failure of an adequate multidisciplinary program, unrealistic expectations, medical instability, or inability to understand/carry out instructions.
- Aggressive and/or violent behavior
- Imminently suicidal tendencies
- Prior failure of an adequate multidisciplinary program
- Unrealistic expectations of immediate cure
- Medically unstable conditions
- Inability to understand and carry out instructions
Policy guidance vs. plan-specific coverage — check plan provisions
Clinical Policy Bulletins provide general guidance for administering benefits but do not guarantee coverage; coverage, benefit limits, and program participation are determined by the member's plan provisions and program disclosures.
Failure of Conventional Treatments
Program Duration and Frequency Limits
Pre-admission Diagnostic and Psychological Testing
Perform pre-admission medical/psychological evaluations outpatient; inpatient testing alone is not appropriate
Diagnostic testing may be part of hospital-level inpatient programs, but pre-admission medical and psychological evaluations should be completed on an outpatient basis; inpatient admission solely for testing is not considered medically necessary.
- Hospital-level programs may include diagnostic testing as part of their services, but pre-admission evaluations are expected to be outpatient.
Background and Context
Chronic pain is pain that persists longer than expected after an illness or injury or that recurs over months or years; it is typically defined as pain present for 6 months or more. Multidisciplinary chronic pain programs address the physical and psychological contributors to persistent pain using coordinated medical management, physical/occupational therapy, behavioral interventions, and patient education to improve function and reduce reliance on analgesic medications.
Definitions
Services Not Covered / Experimental
Not covered under this policy: 1) Modality‑oriented pain clinics and single‑disciplinary pain clinics, which are considered not medically necessary for comprehensive chronic pain management; and 2) specific diagnostic or monitoring technologies listed as experimental or investigational, including the Foundation PISM urine functional biomarker panel and NeuroFlow remote physiologic monitoring, which are considered experimental/investigational and are not covered for chronic pain management as specified.
Coding References and Related Codes
| 0117U | Pain management, analysis of 11 endogenous analytes, LC-MS/MS, urine, algorithm reported as a pain-index score |
| 96132 | Neuropsychological testing evaluation services |
| 96133 | Neuropsychological testing evaluation services (component) |
| 96146 | Psychological or neuropsychological test administration, automated instrument, automated result only |
| 99453 | Remote monitoring of physiologic parameter(s), initial; set-up and patient education |
| 99454 | Remote monitoring device supply with daily recordings or programmed alerts, each 30 days |
| 99457 | Remote physiologic monitoring treatment management services, first 20 minutes |
| 99458 | Remote physiologic monitoring treatment management services, each additional 20 minutes |
| 64553-64595 | Neurostimulators |
| 90785 | Interactive complexity (add-on) |
Revision History
Policy became effective.
Policy last reviewed.
Next scheduled review date.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.